Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,661 | 127,677 | 185,087 | 113,207 | 78,537 |
| Marketable Securities | 184,921 | 205,611 | 162,708 | 122,389 | 162,427 |
| Receivables | 8,117 | 6,224 | 3,328 | 1,707 | 862 |
| Inventories | 5,487 | 2,917 | N/A | N/A | N/A |
| TOTAL | $317,838 | $354,236 | $361,874 | $249,332 | $253,449 |
| Non-Current Assets | |||||
| PPE Net | 2,001 | 2,197 | 2,426 | 2,559 | 2,722 |
| Intangibles | 7,669 | 7,883 | 8,097 | 8,311 | 8,527 |
| Other Non-Current Assets | 18,170 | 18,165 | 17,217 | 17,473 | 20,126 |
| TOTAL | $27,840 | $28,245 | $27,740 | $28,343 | $31,375 |
| Total Assets | $345,678 | $382,481 | $389,614 | $277,675 | $284,824 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,347 | 4,797 | 4,933 | 6,012 | 12,010 |
| Accrued Expenses | 30,549 | 32,894 | 25,741 | 35,605 | 25,199 |
| Other current liabilities | N/A | N/A | N/A | N/A | 9,440 |
| TOTAL | $46,029 | $39,809 | $33,098 | $44,570 | $47,274 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,428 | 1,434 | 1,760 | 2,309 | N/A |
| Other Non-Current Liabilities | 2,366 | 2,600 | 2,360 | 3,204 | 1,781 |
| TOTAL | $79,886 | $78,410 | $75,321 | $37,477 | $1,781 |
| Total Liabilities | $125,915 | $118,219 | $108,419 | $82,047 | $49,055 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,855 | 56,748 | 56,348 | 50,721 | 50,394 |
| Common Shares | 56 | 56 | 56 | 50 | 50 |
| Retained earnings | -762,237 | -710,058 | -667,565 | -626,704 | -581,703 |
| Other shareholders' equity | -6 | -92 | -339 | -906 | -629 |
| TOTAL | $219,763 | $264,262 | $281,195 | $195,628 | $235,769 |
| Total Liabilities And Equity | $345,678 | $382,481 | $389,614 | $277,675 | $284,824 |